INTRODUCTION
============

Diarrhea continues to be a major cause of illness and death worldwide. According to the World Health Organization (WHO), 1.4 million pre-school children die annually due to diarrhea resulting from intestinal infection ([@b19]).

The Pan-American Health Organization (PAHO) reports that the average rate of death from acute diarrhea in children younger than 5 years of age in Latin America and the Caribbean is 4.1%. The regions with the highest rates are Central America (7.8%), the Caribbean (5.5%), and 5.1% in the Andean region ([@b23]). Costa Rica, for example, recorded 450 deaths due to diarrhea during 2001--2005, of which only 20 were found to have an identified causal agent ([@b18]).

*Escherichia coli* is a Gram negative bacillus, a normal microorganism in humans, but one which can produce symptoms of diarrhea when virulent factors are acquired, among which are enterotoxins, adhesines, and colonization factors ([@b33]).

Diarrheogenic varieties of *E. coli* exhibit a wide range of clinical symptoms that include traveler´s diarrhea and hemorrhagic diarrhea ([@b24]) as well as cases produced by zoonosis ([@b14]). To date, six varieties have been clearly described and characterized by virulence factors capable of causing diarrhea in humans: 1) enterotoxigenic *E. coli* or ETEC, whose most distinctive genes are the stable thermotoxin -*st*- and thermolabile -*lt*-; 2) enteropathogenic *E. coli* or EPEC, whose characteristic genes are the intimine --*eaeA*- and the bundle forming pilus --*bfp*-); 3) shiga-toxin *E. coli* or STEC, whose toxins are encoded in the *stx1* y *stx2* genes, 4) enteroinvasive *E. coli* or EIEC, one of whose characteristic virulence traits is the *ipaH*, which belongs to the invasion plasmid; 5) enteroaggregative *E. coli* or EAEC, with the pCVD432 plasmid, for which the *aatA* gene is one of the most stable regions; and 6) diffusely adherent *E. coli* or DAEC, whose virulence genes have yet to be fully profiled ([@b11], [@b22]).

A number of different procedures have been described for identifying these pathogens since this cannot be carried out based on their phenotypical features. These strategies have ranged from cultivating cells to bio-molecular identification, such as Multiplex PCR ([@b1], [@b3], [@b11], [@b20], [@b21]). This means that routine detection of these varieties is costly. Moreover, the literature demonstrates that the frequency of virulent *E. coli* varieties is much lower than that of non-virulent varieties, thus making it necessary to screen various isolates per sample in order to detect them ([@b10]). Costa Rica and most other Latin American countries lack epidemiological data on the circulation of diarrheogenic *E. coli* as well as on its impact on public health. The main goal of the present study was to design a quick and easy screening system that would make analysis of the greatest number of *E. coli* isolates possible, as well as to determine the applicability of the system in both fecal samples from children less than 6 years of age and in wastewater samples taken from stabilization or settling ponds.

METHODOLOGY
===========

Samples
-------

Sixty six fecal samples were collected through a community project at the University of Costa Rica (TCU-350) with children younger than 6 years of age in Montes de Oca county in San José province, Costa Rica, during February and March of 2007. These samples were inoculated in MacConkey agar (Oxoid^®^) within 12 hours after collection, and were incubated at 35 ºC for 24 hours. Moreover, 24 water samples were collected for over a year (from September of 2007 until December of 2008) from inlet and outfall points of the Costa Rican Water Supply and Sewer Institute´s settling ponds located in Nicoya, Cañas, Liberia, Santa Cruz, and Pérez Zeledón. The wastewater samples were processed by the most probable number (MPN) technique for fecal coliforms as described by the American Public Health Association ([@b2]). After the presumptive phase, a mix was made of all tubes that tested positive by dilution. Each subsample (subsamples being understood as each dilution of an analyzed sample that had tested positive) was then inoculated into MacConkey agar (Oxoid^®^) and incubated at 35 ºC for 24 hours.

Gene pool system
----------------

Twenty colonies from the bacterial cultures of the feces and wastewater samples obtained in MacConkey agar (Oxoid^®^) were inoculated in a single tube of soy trypticase broth (Oxoid^®^) and then incubated at 35 ºC for 24 hours. In order to include atypical *E. coli* morphotypes, all the pools were prepared with 25% lactose negative colonies and 75% lactose positive colonies. To be able to assess the detection limit of the method, bacterial pools containing positive control colonies and strains with no virulence factors were utilized; the ratio used was 1:19 (1 positive colony was inoculated with a known virulence factor, along with 19 bacterial strains with not known virulence factors). Pools with 1+1:18 ratios, in which colonies that were carriers of different virulence factors were mixed with strains with not known virulence factors, were also evaluated.

DNA extraction and quantification
---------------------------------

The extraction of the DNA was carried out in accordance with the Franck thermic protocol ([@b7]). The extracted DNA material was stored at -70 ºC until being used. The quantification of the DNA from each pool was carried out with an Epependorff Plus^®^ biophotometer, with a dilution factor of 1:200.

Polymerase Chain Reaction (PCR)
-------------------------------

Two Multiplex PCR and one simple PCR, which had been standardized in the laboratory, were used to process the gene pool samples. For the PCR Multiplex, the following reagent concentration was utilized: free buffer Mg 1X Fermentas^®^, MgCl~2~ 1.75 mM Fermentas^®^, dNTP 200 µM Fermentas^®^, 0.6 U of Taq polymerase Fermentas^®^ per reaction, and 4 µl of bacterial DNA. The primers utilized for the PCR Multiplex 1 were as follows: 5´GAC CCG GCA CAA GCA TAA GC 3´ and 5´CCA CCT GCA GCA ACA AGA GG 3' for the *eaeA* gene (384 pb, 0.04 µg/reaction), 5´AAT GGT GCT TGC GCT TGC TGC 3´ and 5´ GCC GCT TTA TCC AAC CTG GTA3´ for the *bfpA* gene (324 pb, 0.03 µg/reaction), 5´CTG GAT TTA ATG TCG CAT AGT G3´ and 5´AGA ACG CCC ACT GAG ATC ATC3´ for the *stx1* gene (150 pb, 0.045 µg/reaction)*,* 5´GGC ACT GTC TGA AAC TGC TCC 3´ and 5´TCG CCA GTT ATC TGA CAT TCT G3´ for the *stx2* gene (250 pb, 0.06 µg/reaction) ([@b13]) and 5'GTTCCTTGACCGCCTTTCCGATACCGTC3' and 5'GCCGGTCAGCCACCCTCTGAGAGTAC 3' for the *ipaH* gene (600 pb, 0.05 µg/reaction) ([@b4]). The primers utilized for the Multiplex PCR 2 were as follows: 5´ TCT GTA TTG TCT TTT TCA CC 3´ and 5´ TTA ATA GCA CCC GGT ACA AGC 3´ for the *st* toxin (186 pb, 0.4 µg/reaction) ([@b8]), 5' TCT CTA TGT GCA TAC GGA GC 3' and 5' CCA TAC TGA TTG CCG CAA T 3' for the *lt* toxin (322 pb, 0.02 µg/reaction) ([@b30]) and 5´CTG GCG AAA GAC TGT ATC AT 3´ and 5´CAATGTATAGAAATCCGCTGTT 3´ for a segment of the pCVD423 *aatA* gene (630 pb, 0.045 µg/reaction) ([@b27]). Finally, a simple PCR with MasterMix Fermentas^®^ 2X was used for the 16S; as primers, 5'GGGATGAAAGTTAATACCTTTGCTC 3' and 5' TTCCCGAAGGCACATTCT 3' (584 pb) were used ([@b31]). The amplification was done in a DNA thermal cycler (Applied BioSystem^®^) using 5 min at 95 °C for initial denaturation followed by 35 cycles of 92°C (denaturation), 55 °C (annealing) and 72 °C (primer extension), for 45 seconds each, with a final 10 min extension at 72°C). For the simple PCR, the amplification conditions were a initial denaturation for 5 minutes at 94 ºC, followed by 35 cycles of PCR divided in 94 ºC (denaturation), 56 ºC (annealing) and 72 ºC (primer extension), for 30 seconds each, with a final extension of 2 minutes at 72 ºC. The detection limit for all the PCR Multiplex and simple PCR reactions was assessed by utilizing quantified bacterial DNA dilutions (between 10 and 60 ng/µl) and the specificity of the PCR was assessed by using other members of the family *Enterobacteriaceae*. PCR products were visualized by 2% agarose gels (TopVision^TM^ Fermentas^®^) with 0.05% ethydium bromide. The electrophoresis processes were carried out in a Fisher Scientific^®^ electrophoresis chamber at 13.5 V/cm for 60 minutes. DNA fragment sizes were compared to a molecular weight marker (Fermentas^®^), with a 50 base pair ladder.

RESULTS
=======

PCR
---

The optimum conditions of each PCR reaction were standardized in the laboratory and detailed in the methodology. The minimum concentration of DNA detected was of 20 µg/ml for the 16S, the *stx1, stx2,* and *ipaH* genes, and 30 µg/ml for the *eaeA* and *bfpA* genes. In the Multiplex 2 reaction, the minimum concentration of DNA detected was 40 µg/ml. For which extractions of DNA with concentrations of between 60 and 200 µg/ml were used. In the specificity assays amplification was observed only for the 16S gene of *Shigella* sp. strain, whereas no amplification was observed in any of the other genes and strains.

Gene pool system
----------------

The detection limit of the gene pool method was evaluated in order to determine the capacity of detecting the virulence genes of pathogenic *E.coli* strains, which were present in the pool in a much lower concentration as compared to the predominant non virulent *E. coli* strains (1+19). Before the PCR analysis, the DNA obtained for each gene pool was quantified, and positive detections were obtain from the DNA pools in which only one strain was the carrier of virulence factors (1:19); this was done in quintuplicate for each gene under study ([Figure 1](#fig1){ref-type="fig"}). To evaluate the simultaneous detection of the genes, mixed pools were prepared from the positive control strains, an effective detection was achieved for each one of the specific genes. This was carried out in quintuplicate for the *eaeA+/bfpA+, stx1, stx2, ipaH* combinations, and for the *ST+/LT+, aatA* combination.

![A. Multiplex PCR for bacterial positive pool of genes *ST, LT* y *aatA* in the ratio 19:1. 1. Molecular weight marker, 2.DNA pool *eae+/bfpA+*, 3. DNA pool *ST+/LT+*, 4. DNA pool *aatA+*, 5. DNA pool *eae+/stx1+*, 6. DNA pool *eae+/stx2+*, 7. DNA pool *ipaH+*, 8.DNA pool *STt+/LT+/*aatA+, 9. Reagent control. B. Multiplex PCR for bacterial positive pool of genes *eae, bfpA, stx1, stx2* e *ipaH* in the ratio 19:1. 1. Molecular weight marker, 2.DNA pool *eae+/bfpA+*, 3. DNA pool *ST+/LT+*, 4. DNA pool *aatA+*, 5. DNA pool *eae+/stx1+*, 6. DNA pool *eae+/stx2+*, 7. DNA pool *ipaH+*, 8.DNA pool *eae*+/*bfpA*+/*stx1*+/*stx2+/ ipaH*+, 9. DNA pool *ST+/LT+/aatA*+, 10. DNA *E. coli* ATCC 25922, 11. DNA *Enterobacter cloacae*, 12.Reagent control](bjm-43-1319-g001){#fig1}

Fecal samples
-------------

Of the 66 samples analyzed, 1 was discarded since the *16S* gene was not detected by PCR; samples showing negative results for the *16S* gene were excluded since with the established conditions, their detection would be found to be below the sensitivity limit. Thirty-seven percent of the samples yielded negative results, 34% of the samples tested positive for more than one virulence factor, and 24% of the samples tested positive for just one virulence factor. The specific results are detailed in [Table 1](#tbl1){ref-type="table"}.

###### 

Detection frequency (%) in fecal and wastewater samples (input and output of ponds) analyzed virulence genes of *Escherichia coli*.

  Analyzed gene   Fecal sample frequency (%)   Input ponds sample frequency (%)   Output ponds sample frequency (%)   General ponds frequency (%) n=24
  --------------- ---------------------------- ---------------------------------- ----------------------------------- ----------------------------------
  *st*            21,2                         7,7                                \-                                  12,5
  *lt*            15,1                         23,1                               27,3                                25
  *eaeA*          25,7                         23,1                               27,3                                21
  *bfpA*          --                           7,7                                9,1                                 8,3
  *ipaH*          --                           15,4                               18,2                                16,7
  *stx1*          30,3                         --                                 --                                  --
  *stx2*          --                           --                                 --                                  --
  *aatA*          19,7                         7,7                                27,3                                12,5

Wastewater samples
------------------

Of the 24 samples taken from settling ponds, which were analyzed as 77 subsamples, no samples were discarded since in every case at least one subsample showed amplification of the *16S* gene. Thirteen samples were taken from pond inlets, and 11 were taken from their out fall points. Of the total of samples analyzed, 46% were negative for all virulence factors under study, 33.3% were positive for at least one virulence factor, and 12.5% were positive for just one virulence factor. The relative frequencies found are detailed in [Table 1](#tbl1){ref-type="table"}.

DISCUSSION
==========

The gene pool system is an innovative element in this study. It has been widely documented that detection of diarrheagenic varieties of *E.coli* is methodologically complex because this bacterial group is found in low concentrations in fecal samples, and then as a result, analysis from 1 to 5 isolates can yield low detection frequencies ([@b10], [@b16]). We propose that this newly described tool can be used to overcome this limitation.

To work adequately, the gene pool system requires adjustments and standardization of the quantity of genetic material obtained in order to generate reproducible results ([@b28]). In the case of this PCR, to standardize the optimum conditions for amplification and to prevent false negatives because of low DNA concentration, assays were carried out to determine the minimum concentration of DNA necessary for detection of the expected products (between 60 and 200 µg/ml); thus, the results obtained are reproducible.

Moreover, the implemented detection system was assayed in two distinct matrixes in order to evaluate its versatility. Fecal samples were chosen due to the fact that in Latin America it is common to find these bacterial groups among, both symptomatic and asymptomatic populations ([@b26]). On the other hand, settling ponds were selected because they are ecosystems with a great variety of microorganisms where it is likely to find potentially virulent strains ([@b32]).

The feasibility of detecting diarrheagenic *E. coli* in the analysis of samples from wastewater in settling ponds by enhancing the most probable number (MPN) approach is evident. This is what makes this procedure much more accessible than current alternatives, such as concentration techniques by "in situ" filters, or filtering through membranes ([@b2]).

An important thing to note is that all the positive dilutions have to be analyzed by the enhanced approach since, the presence of microorganisms does not follow a statistically normal distribution ([@b2]). This fact was corroborated in this study upon finding the presence of microorganisms in different dilutions of a given sample, regardless of the composition of dilutions themselves.

The settling ponds studied have retention periods of approximately three months, and their effectiveness, from the microbiological standpoint, is measured by the capacity to diminish the microbial load in at least three logarithms ([@b25]). Nevertheless, the survival of pathogenic microorganisms has not been studied in detail. In addition to the detection of the genes under analysis, differences were found among the profiles of genes across the samples taken from the pond inlet and outfall points ([Table 1](#tbl1){ref-type="table"}).

This phenomenon can be explained from the theoretical point of view given that the genome of diarrheagenic varieties of *E. coli* is common to varieties found in the wild, which allows both groups of bacteria to survive in the greater environment ([@b9]). Moreover, there is evidence that some varieties, such as the Shiga toxin producing *E. coli*, can withstand adverse conditions such as changes in temperature or pH level, and even desiccation. Such evidence suggests that settling ponds are ecosystems with the ability to promote survival of potentially pathogenic bacteria even though the ponds are efficient in reducing the number of microorganisms that end up exiting the system. This survival may mean that the ponds recirculate the major virulent varieties of *E. coli* and release them into the environment at different moments, which could explain the variation in the profiles of virulent genes found across the ponds inlet and outfall points.

On the other hand, the system proved capable of detecting diarrheagenic *E. coli* in fecal samples as well. It is important to emphasize that although that the samples were taken from asymptomatic children, the frequencies detected were greater than those usually described, in which only 1 to 3 isolations per sample are analyzed ([@b6]). Among the hypotheses to explain this finding are the following: improved detection thanks to the use of gene pools, a high prevalence of pathotypes in the population, and the fact that these pathogenic varieties are regulated by the surroundings ([@b17], [@b9]). However, future studies are needed in order to analyze this phenomenon in detail.

In the fecal and wastewater samples analyzed, genes were simultaneously found that are characteristic of both ETEC and EPEC; this is a trend that has been described for a number of years, and which at the clinical level produces more severe symptoms than those generated by either of these varieties individually ([@b5]). These findings can serve as a guide for better treatment in the health sector for patients with acute diarrhea that present these co-infections. Nonetheless, studies of this nature are scarce, as mentioned previously, due to routine analysis being carried out by means of profiling 1 to 3 isolations on an individual basis, which could overlook identification of other pathogenic varieties present in a given sample.

Another important finding is the high frequency at which the *eaeA* gene was detected, both in wastewater and fecal samples; this could indicate the presence of atypical ECEP varieties in the country, which is congruent with findings worldwide, where the atypical EPEC varieties are more frequent than typical ones ([@b1]).

Finally, although methodologies currently exist to analyze microorganisms directly in the sample which improves response time, with this system, the cultivation of microorganisms ensures their viability and avoids the problems created by substance inhibitors in the sample for detection by PCR. ([@b12], [@b29])

To summarize, the present study demonstrates the efficiency of implementing a gene pool system for detecting diarrheagenic *E. coli*. This tool is useful for analysis of wastewater and fecal samples, and its implementation in the field is an initial step toward carrying out epidemiological studies to assess the incidence, prevalence, and persistence of certain diarrheagenic *E. coli* varieties. This information can make it possible to orient authorities as to the proper means of environmental control when handling wastewater, as well as to guide those in the clinical field as to the best course of treatment for patients infected with one or more pathogenic varieties of *E. coli*.
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